ALEXANDRIA REAL ESTATE EQUIT (ARE) Stock Fundamental Analysis

NYSE:ARE • US0152711091

53.65 USD
+0.25 (+0.47%)
At close: Feb 20, 2026
53.65 USD
0 (0%)
After Hours: 2/20/2026, 8:17:16 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall ARE gets a fundamental rating of 2 out of 10. We evaluated ARE against 123 industry peers in the Diversified REITs industry. ARE has a bad profitability rating. Also its financial health evaluation is rather negative. ARE does not seem to be growing, but still is valued expensively. Finally ARE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ARE has reported negative net income.
  • In the past year ARE had a positive cash flow from operations.
  • Of the past 5 years ARE 4 years were profitable.
  • In the past 5 years ARE always reported a positive cash flow from operatings.
ARE Yearly Net Income VS EBIT VS OCF VS FCFARE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.22%, ARE is doing worse than 79.67% of the companies in the same industry.
  • ARE has a Return On Equity of -9.30%. This is in the lower half of the industry: ARE underperforms 73.17% of its industry peers.
  • ARE has a Return On Invested Capital of 1.53%. This is in the lower half of the industry: ARE underperforms 74.80% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ARE is in line with the industry average of 3.06%.
Industry RankSector Rank
ROA -4.22%
ROE -9.3%
ROIC 1.53%
ROA(3y)-1.05%
ROA(5y)0.03%
ROE(3y)-2.35%
ROE(5y)-0.18%
ROIC(3y)1.84%
ROIC(5y)1.72%
ARE Yearly ROA, ROE, ROICARE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • ARE's Operating Margin of 20.70% is in line compared to the rest of the industry. ARE outperforms 48.78% of its industry peers.
  • In the last couple of years the Operating Margin of ARE has declined.
  • With a Gross Margin value of 69.39%, ARE perfoms like the industry average, outperforming 56.91% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ARE has remained more or less at the same level.
Industry RankSector Rank
OM 20.7%
PM (TTM) N/A
GM 69.39%
OM growth 3Y-7.87%
OM growth 5Y-5.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5Y-0.7%
ARE Yearly Profit, Operating, Gross MarginsARE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARE is destroying value.
  • Compared to 1 year ago, ARE has less shares outstanding
  • ARE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ARE is higher compared to a year ago.
ARE Yearly Shares OutstandingARE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ARE Yearly Total Debt VS Total AssetsARE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • A Debt/Equity ratio of 0.76 indicates that ARE is somewhat dependend on debt financing.
  • ARE's Debt to Equity ratio of 0.76 is fine compared to the rest of the industry. ARE outperforms 76.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.3
WACC5.04%
ARE Yearly LT Debt VS Equity VS FCFARE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

2.3 Liquidity

  • ARE has a Current Ratio of 0.28. This is a bad value and indicates that ARE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ARE (0.28) is worse than 88.62% of its industry peers.
  • A Quick Ratio of 0.28 indicates that ARE may have some problems paying its short term obligations.
  • ARE's Quick ratio of 0.28 is on the low side compared to the rest of the industry. ARE is outperformed by 86.99% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
ARE Yearly Current Assets VS Current LiabilitesARE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ARE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -568.89%.
  • Looking at the last year, ARE shows a decrease in Revenue. The Revenue has decreased by -6.79% in the last year.
  • Measured over the past years, ARE shows a quite strong growth in Revenue. The Revenue has been growing by 9.84% on average per year.
EPS 1Y (TTM)-568.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1571.05%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y4.13%
Revenue growth 5Y9.84%
Sales Q2Q%-4.5%

3.2 Future

  • Based on estimates for the next years, ARE will show a very strong growth in Earnings Per Share. The EPS will grow by 24.58% on average per year.
  • The Revenue is expected to grow by 0.39% on average over the next years.
EPS Next Y98.64%
EPS Next 2Y39.4%
EPS Next 3Y24.58%
EPS Next 5YN/A
Revenue Next Year-10.34%
Revenue Next 2Y-4.66%
Revenue Next 3Y-1.31%
Revenue Next 5Y0.39%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ARE Yearly Revenue VS EstimatesARE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
ARE Yearly EPS VS EstimatesARE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ARE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARE Price Earnings VS Forward Price EarningsARE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • ARE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ARE is cheaper than 83.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.69
ARE Per share dataARE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ARE's earnings are expected to grow with 24.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.4%
EPS Next 3Y24.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.71%, ARE is a good candidate for dividend investing.
  • ARE's Dividend Yield is comparable with the industry average which is at 6.78.
  • Compared to an average S&P500 Dividend Yield of 1.85, ARE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.71%

5.2 History

  • The dividend of ARE has a limited annual growth rate of 5.18%.
  • ARE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ARE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.18%
Div Incr Years14
Div Non Decr Years14
ARE Yearly Dividends per shareARE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • ARE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of ARE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-63.38%
EPS Next 2Y39.4%
EPS Next 3Y24.58%
ARE Yearly Income VS Free CF VS DividendARE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B

More info and screens

Find the best dividend stocksShow peers with best dividend

ALEXANDRIA REAL ESTATE EQUIT

NYSE:ARE (2/20/2026, 8:17:16 PM)

After market: 53.65 0 (0%)

53.65

+0.25 (+0.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)01-26
Earnings (Next)04-27
Inst Owners97.93%
Inst Owner Change-4.69%
Ins Owners0.88%
Ins Owner Change11.38%
Market Cap9.30B
Revenue(TTM)3.01B
Net Income(TTM)-1.44B
Analysts68.57
Price Target66.74 (24.4%)
Short Float %5.39%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 5.71%
Yearly Dividend5.32
Dividend Growth(5Y)5.18%
DP-63.38%
Div Incr Years14
Div Non Decr Years14
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1353.23%
Min EPS beat(2)-2332.09%
Max EPS beat(2)-374.36%
EPS beat(4)0
Avg EPS beat(4)-755.59%
Min EPS beat(4)-2332.09%
Max EPS beat(4)-110.31%
EPS beat(8)2
Avg EPS beat(8)-400.9%
EPS beat(12)2
Avg EPS beat(12)-296.3%
EPS beat(16)4
Avg EPS beat(16)-217.38%
Revenue beat(2)0
Avg Revenue beat(2)-1.45%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)-0.07%
Revenue beat(8)2
Avg Revenue beat(8)-1.77%
Revenue beat(12)5
Avg Revenue beat(12)-0.19%
Revenue beat(16)9
Avg Revenue beat(16)7.91%
PT rev (1m)1.5%
PT rev (3m)-31.79%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-62.96%
EPS NY rev (1m)-203.03%
EPS NY rev (3m)-110.25%
Revenue NQ rev (1m)-4.35%
Revenue NQ rev (3m)-6.54%
Revenue NY rev (1m)-2.45%
Revenue NY rev (3m)-9.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.08
P/FCF N/A
P/OCF 6.58
P/B 0.6
P/tB 0.61
EV/EBITDA 10.69
EPS(TTM)-8.44
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-2.64
FCFYN/A
OCF(TTM)8.16
OCFY15.21%
SpS17.39
BVpS89.27
TBVpS88.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.22%
ROE -9.3%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.56%
ROICexgc 1.57%
OM 20.7%
PM (TTM) N/A
GM 69.39%
FCFM N/A
ROA(3y)-1.05%
ROA(5y)0.03%
ROE(3y)-2.35%
ROE(5y)-0.18%
ROIC(3y)1.84%
ROIC(5y)1.72%
ROICexc(3y)1.87%
ROICexc(5y)1.75%
ROICexgc(3y)1.88%
ROICexgc(5y)1.77%
ROCE(3y)2.33%
ROCE(5y)2.17%
ROICexgc growth 3Y-2.95%
ROICexgc growth 5Y-4.61%
ROICexc growth 3Y-2.57%
ROICexc growth 5Y-4.42%
OM growth 3Y-7.87%
OM growth 5Y-5.71%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.6%
GM growth 5Y-0.7%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 5.95
Cap/Depr 138.54%
Cap/Sales 62.07%
Interest Coverage 3.06
Cash Conversion 71.61%
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z N/A
F-Score5
WACC5.04%
ROIC/WACC0.3
Cap/Depr(3y)232.54%
Cap/Depr(5y)446.25%
Cap/Sales(3y)89.63%
Cap/Sales(5y)171.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-568.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1571.05%
EPS Next Y98.64%
EPS Next 2Y39.4%
EPS Next 3Y24.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y4.13%
Revenue growth 5Y9.84%
Sales Q2Q%-4.5%
Revenue Next Year-10.34%
Revenue Next 2Y-4.66%
Revenue Next 3Y-1.31%
Revenue Next 5Y0.39%
EBIT growth 1Y-34.56%
EBIT growth 3Y-4.07%
EBIT growth 5Y3.56%
EBIT Next Year253.98%
EBIT Next 3Y62.11%
EBIT Next 5Y43.42%
FCF growth 1Y60.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.01%
OCF growth 3Y2.99%
OCF growth 5Y9.89%

ALEXANDRIA REAL ESTATE EQUIT / ARE FAQ

What is the fundamental rating for ARE stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARE.


What is the valuation status of ALEXANDRIA REAL ESTATE EQUIT (ARE) stock?

ChartMill assigns a valuation rating of 1 / 10 to ALEXANDRIA REAL ESTATE EQUIT (ARE). This can be considered as Overvalued.


Can you provide the profitability details for ALEXANDRIA REAL ESTATE EQUIT?

ALEXANDRIA REAL ESTATE EQUIT (ARE) has a profitability rating of 3 / 10.


How financially healthy is ALEXANDRIA REAL ESTATE EQUIT?

The financial health rating of ALEXANDRIA REAL ESTATE EQUIT (ARE) is 1 / 10.